Le Lézard
Classified in: Business
Subjects: ERN, CCA

Canfor Corporation and Canfor Pulp Products Inc. Announce Second Quarter Results Conference Call

VANCOUVER, June 14, 2019 /CNW/ - Canfor Corporation will hold a joint conference call with Canfor Pulp Products Inc. (TSX:CFX) on Friday, July 26, 2019 at 8:00 AM PDT to discuss their respective second quarter 2019 financial and operating results. To participate in the call, please dial one of the following numbers:

Toll-Free Access:  1-888-390-0546
Access: 1-416-764-8668

Let the operator know you wish to participate in the Canfor conference call.

Following management's discussion of the quarterly results, the analyst and investment community will be invited to ask questions.

For Instant Replay Access please dial one of the following numbers and enter
Toll-Free Access: 1-888-390-0541
Access: 1-416-764-8677
Participant Passcode: 728808#
Recording available until: August 9, 2019

The conference call will be available live at www.canfor.com

Canfor is a leading integrated forest products company based in Vancouver, British Columbia ("BC") with interests in BC, Alberta, North and South Carolina, Alabama, Georgia, Mississippi and Arkansas, as well as in Sweden with its recent majority acquisition of Vida Group. Canfor produces primarily softwood lumber and also owns a 54.8% interest in Canfor Pulp Products Inc., which is one of the largest global producers of market northern bleached softwood kraft pulp and a leading producer of high performance kraft paper. Canfor shares are traded on The Toronto Stock Exchange under the symbol CFP.

SOURCE Canfor Corporation

These press releases may also interest you

at 07:05
Motus GI Holdings, Inc., ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal...

at 07:05
BioXcel Therapeutics, Inc. ("BTI" or "Company") , a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced its quarterly results for the third...

at 07:05
BELLUS Health Inc. ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today reported its financial and...

at 07:05
Viacom Inc. today reported financial results for the quarter and full year ended September 30th, 2019. Statement from Bob Bakish, President & CEO "Our strong performance in the fourth quarter capped off a pivotal year for Viacom and reflects the...

at 07:00
Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, today announced an option, research and license agreement worth up to USD 100 million. The partnership will leverage Dewpoint's proprietary platform...

at 07:00
An investor group led by Leonard Green & Partners, L.P. ("LGP"), in partnership with Arsenal Capital Partners ("Arsenal") and Novo Holdings, today announced that they have agreed to terms on a recapitalization of WCG. The recapitalization was...

News published on 14 june 2019 at 17:00 and distributed by: